Corvus Pharmaceuticals Statistics

Total Valuation

CRVS has a market cap or net worth of $319.25 million. The enterprise value is $276.20 million.

Market Cap	319.25M
Enterprise Value	276.20M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, after market close.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

CRVS has 77.11 million shares outstanding. The number of shares has increased by 37.23% in one year.

Current Share Class	77.11M
Shares Outstanding	77.11M
Shares Change (YoY)	+37.23%
Shares Change (QoQ)	+9.96%
Owned by Insiders (%)	3.83%
Owned by Institutions (%)	32.82%
Float	62.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.72
P/TBV Ratio	6.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.90, with a Debt / Equity ratio of 0.02.

Current Ratio	4.90
Quick Ratio	4.79
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -100.13% and return on invested capital (ROIC) is -45.97%.

Return on Equity (ROE)	-100.13%
Return on Assets (ROA)	-39.21%
Return on Invested Capital (ROIC)	-45.97%
Return on Capital Employed (ROCE)	-62.24%
Revenue Per Employee	n/a
Profits Per Employee	-$1.34M
Employee Count	31
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +117.90% in the last 52 weeks. The beta is 0.57, so CRVS's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	+117.90%
50-Day Moving Average	3.88
200-Day Moving Average	5.25
Relative Strength Index (RSI)	53.67
Average Volume (20 Days)	1,126,427

Short Selling Information

The latest short interest is 8.90 million, so 11.55% of the outstanding shares have been sold short.

Short Interest	8.90M
Short Previous Month	7.94M
Short % of Shares Out	11.55%
Short % of Float	14.15%
Short Ratio (days to cover)	9.84

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.22M
Pretax Income	n/a
Net Income	-41.40M
EBITDA	-31.13M
EBIT	-31.22M
Earnings Per Share (EPS)	-$0.99

Full Income Statement

Balance Sheet

The company has $44.21 million in cash and $1.15 million in debt, giving a net cash position of $43.06 million or $0.56 per share.

Cash & Cash Equivalents	44.21M
Total Debt	1.15M
Net Cash	43.06M
Net Cash Per Share	$0.56
Equity (Book Value)	49.33M
Book Value Per Share	0.72
Working Capital	36.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$28.53 million and capital expenditures -$36,000, giving a free cash flow of -$28.57 million.

Operating Cash Flow	-28.53M
Capital Expenditures	-36,000
Free Cash Flow	-28.57M
FCF Per Share	-$0.37

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRVS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.23%
Shareholder Yield	-37.23%
Earnings Yield	-12.97%
FCF Yield	-8.95%

Analyst Forecast

The average price target for CRVS is $15.00, which is 262.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	262.32%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2